Molecular and Cellular Biology, February 2001, p. 1024-1035, Vol. 21, No. 4
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.4.1024-1035.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
B Kinase-Induced
SCF
TrCP-Mediated Ubiquitination and Degradation for the
NF-
B Precursor p105 and I
B
andMax-Delbrück-Center for Molecular Medicine, 13122 Berlin, Germany
Received 2 August 2000/Returned for modification 26 September 2000/Accepted 15 November 2000
p105 (NFKB1) acts in a dual way as a cytoplasmic I
B molecule and
as the source of the NF-
B p50 subunit upon processing. p105 can form
various heterodimers with other NF-
B subunits, including its own
processing product, p50, and these complexes are signal responsive.
Signaling through the I
B kinase (IKK) complex invokes p105
degradation and p50 homodimer formation, involving p105 phosphorylation
at a C-terminal destruction box. We show here that IKK
phosphorylation of p105 is direct and does not require kinases
downstream of IKK. p105 contains an IKK docking site located in a death
domain, which is separate from the substrate site. The substrate
residues were identified as serines 923 and 927, the latter of which
was previously assumed to be a threonine. S927 is part of a conserved
DSG
motif and is functionally most critical. The region containing
both serines is homologous to the N-terminal destruction box of
I
B
, -
, and -
. Upon phosphorylation by IKK, p105 attracts
the SCF E3 ubiquitin ligase substrate recognition molecules
TrCP1
and
TrCP2, resulting in polyubiquitination and complete degradation
by the proteasome. However, processing of p105 is independent of IKK
signaling. In line with this and as a physiologically relevant model,
lipopolysaccharide (LPS) induced degradation of endogenous p105 and p50
homodimer formation, but not processing in pre-B cells. In mutant pre-B
cells lacking IKK
, processing was unaffected, but LPS-induced p105
degradation was abolished. Thus, a functional endogenous IKK complex is
required for signal-induced p105 degradation but not for processing.
Present address: Department of Pathology, Cornell University
Medical College, New York, NY 10021.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|